1. Recombinant gp19 as a potential antigen for detecting anti-Ehrlichia canis antibodies in dog sera.
- Author
-
Oliveira RS, Cunha RC, Moraes-Filho J, Gonçales RA, Lara AP, Avila LF, Labruna MB, and Leite FP
- Subjects
- Animals, Brazil, Dogs, Ehrlichiosis blood, Ehrlichiosis diagnosis, Recombinant Proteins immunology, Serologic Tests, Antibodies, Bacterial blood, Antigens, Bacterial immunology, Dog Diseases blood, Dog Diseases diagnosis, Ehrlichia canis immunology, Ehrlichiosis veterinary
- Abstract
The canine monocytic ehrlichiosis, caused by Ehrlichia canis, is endemic in several regions of Brazil. Some serological diagnostic techniques using immunodominant proteins of E. canis as antigens are available, but their specificities and sensitivities are questionable. Based on this, the objective of this study was to test the antigenic potential of the recombinant gp19 protein (rGP19) for subsequent use in diagnostic tests. The rGP19 expressed in the Escherichia coli strain BL21 (DE3) C41 was recognized in the sera from experimentally infected dogs using ELISA and Western blotting. Thus, it was possible to obtain a promising antigen with the ability to differentiate between E. canis-positive and -negative animals, even 1 week after infection.
- Published
- 2015
- Full Text
- View/download PDF